2 August 2013
Further to the announcement made on 31 May 2013 about a preliminary approach for the Medical division, Smiths Group announces that it has not proved possible to reach agreement with the potential counterparty on acceptable terms for a transaction. Discussions have therefore been terminated.
In reaching this conclusion, the Board has taken full account of the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths honoured at the London Stock Exchange
Read our latest company news as Smiths is honoured at the London Stock Exchange.
Find out more
Smiths appoints new independent Non-executive Director
Read our latest company news as the Board of Smiths is pleased to announce the appointment of Laurence Mulliez as an independent Non-executive Director, with effect from 1 September 2026.
Find out more
Smiths Group plc – Q3 trading update
Find out more
